Latest FARALLON CAPITAL MANAGEMENT LLC Stock Portfolio
$21.19Billion– No. of Holdings #149
FARALLON CAPITAL MANAGEMENT LLC Performance:
2024 Q2: 1.21%YTD: 9.46%2023: 17.29%
Performance for 2024 Q2 is 1.21%, and YTD is 9.46%, and 2023 is 17.29%.
About FARALLON CAPITAL MANAGEMENT LLC and 13F Hedge Fund Stock Holdings
FARALLON CAPITAL MANAGEMENT LLC is a hedge fund based in SAN FRANCISCO, CA. On 20-Jul-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $41.2 Billions. In it's latest 13F Holdings report, FARALLON CAPITAL MANAGEMENT LLC reported an equity portfolio of $21.2 Billions as of 30 Jun, 2024.
The top stock holdings of FARALLON CAPITAL MANAGEMENT LLC are UNH, CRM, IQV. The fund has invested 3.9% of it's portfolio in UNITEDHEALTH GROUP INC and 3.6% of portfolio in SALESFORCE INC.
The fund managers got completely rid off PIONEER NAT RES CO (PXD), COSTAR GROUP INC (CSGP) and INSPIRE MED SYS INC (INSP) stocks. They significantly reduced their stock positions in HIMS & HERS HEALTH INC (HIMS), IONIS PHARMACEUTICALS INC (IONS) and AVIDITY BIOSCIENCES INC (RNA). FARALLON CAPITAL MANAGEMENT LLC opened new stock positions in DISNEY WALT CO (DIS), AMGEN INC (AMGN) and INSMED INC (INSM). The fund showed a lot of confidence in some stocks as they added substantially to CRINETICS PHARMACEUTICALS IN (CRNX), CENTESSA PHARMACEUTICALS PLC (CNTA) and AON PLC (AON).
The top stock holdings of FARALLON CAPITAL MANAGEMENT LLC are UNH, CRM, IQV. The fund has invested 3.9% of it's portfolio in UNITEDHEALTH GROUP INC and 3.6% of portfolio in SALESFORCE INC.
The fund managers got completely rid off PIONEER NAT RES CO (PXD), COSTAR GROUP INC (CSGP) and INSPIRE MED SYS INC (INSP) stocks. They significantly reduced their stock positions in HIMS & HERS HEALTH INC (HIMS), IONIS PHARMACEUTICALS INC (IONS) and AVIDITY BIOSCIENCES INC (RNA). FARALLON CAPITAL MANAGEMENT LLC opened new stock positions in DISNEY WALT CO (DIS), AMGEN INC (AMGN) and INSMED INC (INSM). The fund showed a lot of confidence in some stocks as they added substantially to CRINETICS PHARMACEUTICALS IN (CRNX), CENTESSA PHARMACEUTICALS PLC (CNTA) and AON PLC (AON).
FARALLON CAPITAL MANAGEMENT LLC Equity Portfolio Value
Last Reported on: 14 Aug, 2024
FARALLON CAPITAL MANAGEMENT LLC Annual Return Estimates Vs S&P 500
Our best estimate is that FARALLON CAPITAL MANAGEMENT LLC made a return of 1.21% in the last quarter. In trailing 12 months, it's portfolio return was 15.31%.
New Buys
| Ticker | $ Bought |
|---|---|
| disney walt co | 355,673,000 |
| amgen inc | 72,488,400 |
| insmed inc | 38,056,000 |
| flutter entmt plc | 36,617,900 |
| crispr therapeutics ag | 28,625,300 |
| twist bioscience corp | 9,461,760 |
| tectonic therapeutic inc | 7,098,740 |
| biodesix inc | 2,873,610 |
New stocks bought by FARALLON CAPITAL MANAGEMENT LLC
Additions
| Ticker | % Inc. |
|---|---|
| crinetics pharmaceuticals in | 9,840 |
| centessa pharmaceuticals plc | 438 |
| aon plc | 196 |
| biohaven ltd | 181 |
| metals acquisition limited | 160 |
| new oriental ed & technology | 138 |
| geron corp | 124 |
| progyny inc | 120 |
Additions to existing portfolio by FARALLON CAPITAL MANAGEMENT LLC
Reductions
| Ticker | % Reduced |
|---|---|
| hims & hers health inc | -99.4 |
| ionis pharmaceuticals inc | -99.35 |
| avidity biosciences inc | -99.18 |
| humana inc | -98.84 |
| arcutis biotherapeutics inc | -98.54 |
| pacific biosciences calif in | -96.42 |
| altimmune inc | -94.13 |
| lufax holding ltd | -90.00 |
FARALLON CAPITAL MANAGEMENT LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| joyy inc | -10,323,900 |
| gossamer bio inc | -7,233,720 |
| vestis corporation | -94,707,300 |
| pioneer nat res co | -924,000,000 |
| costar group inc | -250,615,000 |
| grayscale bitcoin tr btc | -85,221,200 |
| evolent health inc | -34,014,100 |
| screaming eagle acquisitn co | -10,700,000 |
FARALLON CAPITAL MANAGEMENT LLC got rid off the above stocks
Sector Distribution
FARALLON CAPITAL MANAGEMENT LLC has about 40.4% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 40.4 |
| Technology | 16.3 |
| Financial Services | 12.2 |
| Industrials | 10.8 |
| Communication Services | 8.2 |
| Others | 6.5 |
| Real Estate | 2.3 |
| Consumer Cyclical | 1.8 |
| Basic Materials | 1.3 |
Market Cap. Distribution
FARALLON CAPITAL MANAGEMENT LLC has about 69.5% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| LARGE-CAP | 46.9 |
| MID-CAP | 22.7 |
| MEGA-CAP | 22.6 |
| UNALLOCATED | 6.1 |
| SMALL-CAP | 1.3 |
Stocks belong to which Index?
About 70.4% of the stocks held by FARALLON CAPITAL MANAGEMENT LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| S&P 500 | 59 |
| Others | 29.6 |
| RUSSELL 2000 | 11.4 |
FARALLON CAPITAL MANAGEMENT LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of FARALLON CAPITAL MANAGEMENT LLC
FARALLON CAPITAL MANAGEMENT LLC has 149 stocks in it's portfolio. About 27.9% of the portfolio is in top 10 stocks. IQV proved to be the most loss making stock for the portfolio. GOOG was the most profitable stock for FARALLON CAPITAL MANAGEMENT LLC last quarter.
Last Reported on: 14 Aug, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ABC | cencora inc | 0.26 | 242,800 | 54,702,800 | reduced | -27.31 | ||
| ABNB | airbnb inc | 1.22 | 1,701,000 | 257,923,000 | added | 5.77 | ||
| ACHC | acadia healthcare company in | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ACLX | arcellx inc | 0.00 | 4,000 | 220,760 | unchanged | 0.00 | ||
| ADI | analog devices inc | 1.38 | 1,284,800 | 293,268,000 | reduced | -16.46 | ||
| AGIO | agios pharmaceuticals inc | 1.15 | 5,654,500 | 243,822,000 | added | 1.14 | ||
| AGLE | spyre therapeutics inc | 0.07 | 666,000 | 15,657,700 | added | 42.92 | ||
| ALNY | alnylam pharmaceuticals inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ALPN | alpine immune sciences inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ALT | altimmune inc | 0.00 | 27,600 | 183,540 | reduced | -94.13 | ||
| AMGN | amgen inc | 0.34 | 232,000 | 72,488,400 | new | |||
| AMLX | amylyx pharmaceuticals inc | 0.01 | 1,150,220 | 2,185,420 | unchanged | 0.00 | ||
| AON | aon plc | 2.60 | 1,875,200 | 550,521,000 | added | 196 | ||
| APLS | apellis pharmaceuticals inc | 0.00 | 6,000 | 230,160 | unchanged | 0.00 | ||
| ARDX | ardelyx inc | 0.00 | 23,000 | 170,430 | unchanged | 0.00 | ||
| ARMK | aramark | 2.72 | 16,929,200 | 575,933,000 | reduced | -5.01 | ||
| ARQT | arcutis biotherapeutics inc | 0.00 | 26,000 | 241,800 | reduced | -98.54 | ||
| ARYD | arya sciences acqu corp iv | 0.01 | 200,000 | 2,292,000 | unchanged | 0.00 | ||
| AXSM | axsome therapeutics inc | 0.00 | 4,000 | 322,000 | unchanged | 0.00 | ||
| BABA | alibaba group hldg ltd | 0.00 | 0.00 | 0.00 | sold off | -100 | ||